India to New Zealand: Oseltamivir Export Trade Route

The India to New Zealand Oseltamivir corridor is one of India's established pharmaceutical export routes, with 5 shipments documented worth a combined $1.5M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's oseltamivir manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $304.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during July–September, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 19.2%, placing it at rank #17 among India's top oseltamivir export destinations globally.

On the import side, key buyers of Indian oseltamivir in New Zealand include VIATRIS LIMITED,, Consignee Master & Owner Of SPIRIT. VIATRIS LIMITED, is the single largest importer with 4 shipments valued at $1.5M USD.

India's oseltamivir exports to New Zealand are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in New Zealand benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MYLAN LABORATORIES LIMITED, TULSI MEDICAL & GENERAL STORES — together account for 100% of total trade value on this route. The average shipment value of $304.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicines :- oseltamivir viatris cap 75mg 10bl nz (112,292.000 packs) and oseltavac 75mg cap oseltamivir 75mg cap, suggesting that buyers in New Zealand tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, VIATRIS LIMITED, is the largest importer with 4 shipments worth $1.5M USD — representing 100% of all oseltamivir imports from India on this route.